Get the Stockscreener App
1.15
4.55%
0.05
Pre-market:
1.19
0.04
+3.48%
Co Diagnostics Inc stock is traded at $1.15, with a volume of 419.91K.
It is up +4.55% in the last 24 hours and down -5.74% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$1.10
Open:
$1.11
24h Volume:
419.91K
Relative Volume:
0.98
Market Cap:
$8.03M
Revenue:
$513.90K
Net Income/Loss:
$-48.50M
P/E Ratio:
-0.0411
EPS:
-28.0101
Net Cash Flow:
$-28.99M
1W Performance:
+22.30%
1M Performance:
-5.74%
6M Performance:
-49.34%
1Y Performance:
-87.42%
1-Day Range:
$1.09
$1.17
1-Week Range:
$0.9057
$1.17
52-Week Range:
$0.9057
$13.54
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 438-1036
Address
2401 S FOOTHILL DRIVE, SALT LAKE CITY
Compare CODX vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
1.15 | 8.03M | 513.90K | -48.50M | -28.99M | -28.01 |
ABT
Abbott Laboratories
|
101.07 | 174.89B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.51 | 113.22B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
269.75 | 103.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.68 | 64.75B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.73 | 49.41B | 6.30B | 1.07B | 1.09B | 1.8406 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
Co-Diagnostics, Inc. (CODX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Co-Diagnostics, Inc. (CODX) Latest Stock News & Headlines - Yahoo Finance
Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week - PR Newswire
Co-Diagnostics Preps for New Instrument Launch While Growing Rapid PCR Business Abroad - GenomeWeb
Up to 1-for-50 reverse split on table at Co-Diagnostics (NASDAQ: CODX) - Stock Titan
CODX Stock Explodes Over 630% In Six Sessions – Retail Traders Bet The Rally Isn’t Over Yet - Stocktwits
Co-Diagnostics joins global roundtable on Ebola... - Pluang
Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation - PR Newswire
CODX Stock Price, Quote & Chart - ChartMill
Co-Diagnostics (NASDAQ: CODX) Announces Investor Presentation on ReadyGo Partnership and Development Progress - Kalkine Media
WHO supports tongue swabs for tuberculosis testing. Co-Diagnostics is studying a test designed to meet the guidance. - Stock Titan
Form 8K CO-DIAGNOSTICS For: 16 September By Investing.com - Investing.com Nigeria
Co-Diagnostics, Inc. (CODX) Shareholder/Analyst CallSlideshow (NASDAQ:CODX) 2026-09-16 - Seeking Alpha
Co-Diagnostics partners with ReadyGo on blood-based testing By Investing.com - Investing.com Nigeria
Co-Diagnostics partners with ReadyGo on blood-based testing - Investing.com
Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola - PR Newswire
Co-Diagnostics, Inc. (NASDAQ:CODX) To Evaluate Blood-Based PCR With ReadyGo - TradingView
CODX Looks 33.3% Undervalued on GF Value™ Despite Challenging Fu - gurufocus.com
Co-Diagnostics enters agreement with ReadyGo Diagnostics for technology evaluation By Investing.com - Investing.com Nigeria
Form 8K CO-DIAGNOSTICS For: 15 September By Investing.com - Investing.com Canada
Co-Diagnostics to host press conference and web... - Pluang
A diagnostics CEO will take questions in New York - Stock Titan
Co-Diagnostics (CODX) finance EVP details RSU grants vesting through 2028 - Stock Titan
Q1 2026 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida - PR Newswire
Co-Diagnostics Inc (CODX) Stock News Today - tradingkey.com
United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday - Benzinga
Weekly Recap: International Vector Smart kit deployment and CFO resignation - TradingView
Co-Diagnostics Appoints New Principal Financial Officer - The Globe and Mail
Co-Diagnostics, Inc. Announces Executive Changes, Effective September 2, 2026 - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
CODX Looks 32.6% Undervalued on GF Value™ Amid Challenging Funda - GuruFocus
Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India - Morningstar
Co-Diagnostics, Inc. SEC Filing (Sep 2, 2026) - Stock Titan
CODX Looks 31.4% Undervalued on GF Value™ - GuruFocus
A mosquito surveillance system reaches an overseas U.S. Air Force base - Stock Titan
Co-Diagnostics Inc. (CODX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
CODX Q1 2026 Earnings: Wider-than-Expected Loss as Revenue Remains AbsentAnalyst Coverage Count - careplusvn.com
CODX Forecast — Price Target — Prediction for 2027 - TradingView
ARMISTICE CAPITAL, LLC Buys Co-Diagnostics Inc (CODX) -- Shares Look 33% Undervalued on GF Value - GuruFocus
Co-Dx (CODX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Co-diagnostics Company Profile & Introduction - Moomoo
Co-Diagnostics (CODX) Snapshot: Ends Up by 4.37% at $1.31 in the Current Update; Chart View - vinanet.vn
Co-Diagnostics (CODX) Financial Results: EPS Falls Short of Its Estimate for This Review; Price Reaction: Shares Move 5.97% Lower in the Available RecordEarnings Call Q&A - vinanet.vn
Co-Diagnostics seeks FDA clearance for new PCR Flu A/B & RSV test, prepping for U.S. launch. - Pluang
Co-Diagnostics joins Utah roundtable on AI and medical devices - Stock Titan
Why Did CODX Stock Nearly Double In Value Today? - Stocktwits
Maxim Group Upgrades Co-Diagnostics to Buy From Hold, $4 Price Target - marketscreener.com
Co-Diagnostics Inc (CODX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Company-diagnostics Stock Price Forecast. Should You Buy CODX? - StockInvest.us
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.31%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):